Mikhail Reibarkh

Statistics

Publications

Citations

H-Index

Active since

1997

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Harvard University

Seton Hall University

Merck Institute for Science Education

Mikhail Reibarkh is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in chemistry, medicinal chemistry, and natural sciences.

ORCID

Publications per year

1997–2024

Publications

Small-Molecule Inhibition of the Interaction between the Translation Initiation Factors eIF4E and eIF4G

Nathan J. Moerke, Hüseyin Aktaş, Han Chen et al. · Cell · 2007 · 570 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

A multifunctional catalyst that stereoselectively assembles prodrugs

Daniel A. DiRocco, Yining Ji, Edward C. Sherer et al. · Science · 2017 · 188 citations

Natural Sciences, Chemistry, Medicinal Chemistry +14

Oxyfunctionalization of the Remote C−H Bonds of Aliphatic Amines by Decatungstate Photocatalysis

Danielle M. Schultz, François Lévesque, Daniel A. DiRocco et al. · Angewandte Chemie International Edition · 2017 · 169 citations

Natural Sciences, Chemical Engineering, Chemistry +17

Small molecule inhibition of phosphatidylinositol-3,4,5-triphosphate (PIP3) binding to pleckstrin homology domains

Benchun Miao, Igor Skidan, Jinsheng Yang et al. · Proceedings of the National Academy of Sciences · 2010 · 135 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Selective Pharmacological Targeting of a DEAD Box RNA Helicase

Lisa Lindqvist, Monika Oberer, Mikhail Reibarkh et al. · PLoS ONE · 2008 · 129 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

1–5 of 60